首页> 外文期刊>Integrative Medicine Research >Current knowledge on alleviating Helicobacter pylori infections through the use of some commonly known natural products: bench to bedside
【24h】

Current knowledge on alleviating Helicobacter pylori infections through the use of some commonly known natural products: bench to bedside

机译:通过使用一些众所周知的天然产物减轻从头开始的幽门螺杆菌感染的知识

获取原文
       

摘要

Abstract Helicobacter pylori, a spiral-shaped Gram-negative bacterium, has been classified as a class I carcinogen by the World Health Organization and recognized as the causative agent for peptic ulcers, duodenal ulcer, gastritis, mucosa-associated lymphoid tissue lymphomas, and gastric cancer. Owing to their alarming rate of drug resistance, eradication of H. pylori remains a global challenge. Triple therapy consisting of a proton pump inhibitor, clarithromycin, and either amoxicillin or metronidazole, is generally the recommended standard for the treatment of H. pylori infection. Complementary and alternative medicines have a long history in the treatment of gastrointestinal ailments and various compounds has been tested for anti-H. pylori activity both in vitro and in vivo; however, their successful use in human clinical trials is sporadic. Hence, the aim of this review is to analyze the role of some well-known natural products that have been tested in clinical trials in preventing, altering, or treating H. pylori infections. Whereas some in vitro and in vivo studies in the literature have demonstrated the successful use of a few potential natural products for the treatment of H. pylori-related infections, others indicate a need to consider natural products, with or without triple therapy, as a useful alternative in treating H. pylori-related infections. Thus, the reported mechanisms include killing of H. pylori urease inhibition, induction of bacterial cell damage, and immunomodulatory effect on the host immune system. Furthermore, both in vitro and in vivo studies have demonstrated the successful use of some potential natural products for the treatment of H. pylori-related infections. Nevertheless, the routine prescription of potential complementary and alternative medicines continues to be restrained, and evidence on the safety and efficacy of the active compounds remains a subject of ongoing debate.
机译:摘要幽门螺杆菌是一种螺旋形革兰氏阴性细菌,已被世界卫生组织列为I类致癌物,并且被认为是消化性溃疡,十二指肠溃疡,胃炎,粘膜相关淋巴组织淋巴瘤和胃癌的病原体。癌症。由于其惊人的耐药率,根除幽门螺杆菌仍然是全球性挑战。通常推荐将由质子泵抑制剂,克拉霉素,阿莫西林或甲硝唑组成的三联疗法用于治疗幽门螺杆菌感染。补充药物和替代药物在治疗胃肠道疾病方面已有很长的历史,并且各种化合物已针对抗H进行了测试。体内和体外的幽门螺杆菌活性;然而,它们在人类临床试验中的成功应用是零星的。因此,本综述的目的是分析一些在临床试验中已经测试过的知名天然产物在预防,改变或治疗幽门螺杆菌感染中的作用。文献中的一些体外和体内研究表明,成功地使用了一些潜在的天然产物来治疗幽门螺杆菌相关感染,而另一些研究表明,需要将经过或不经过三联疗法的天然产物视为治疗幽门螺杆菌相关感染的有用替代方法。因此,报道的机制包括杀死幽门螺杆菌脲酶抑制,诱导细菌细胞损伤以及对宿主免疫系统的免疫调节作用。此外,体外和体内研究均已证明成功地将某些潜在的天然产物用于治疗幽门螺杆菌相关感染。然而,潜在的补充和替代药物的常规处方继续受到限制,有关活性化合物安全性和有效性的证据仍然是一个不断争论的话题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号